FAQs (Frequently Asked Questions)
What is the 4th Cell Therapy Potency Assay Summit?Â
The 4th Cell Therapy Potency Assay Summit is the premier event focused on optimizing potency assay development for cell therapies. It will take place from March 12-13, 2025, in Boston, MA. The summit brings together expert in analytical development, quality control, and regulatory compliance to share insights and strategies on how they have optimised their potency assay development towards BLA submission and clinical progression.
The summit is ideal for industry professionals and academic experts involved in cell therapy, including those working in analytical development, biomarker discovery, cytotoxicity testing, cell processing, assay process development, and bioassay development. It is also relevant for those in quality control, regulatory affairs, and tech transfer.Â
Who Should Attend the Summit?
What Topics Will Be Covered at the Summit?
Attendees will gain valuable insights into the latest FDA potency guidelines, learn about new technologies for assay development, and network with industry leaders. The summit offers hands-on workshops, expert panel discussions, and opportunities to collaborate with analytical peers.Â
What are the Benefits of Attending the Summit?
How Can I Register for the Summit?
You can register for the summit by visiting our registration page or contacting us at  [email protected]. Early registration discounts are available.
Yes, we offer team discounts:
10% discount for 2 attendees
15% discount for 3 attendees
20% discount for 4 or more attendees
Are There Any Discounts Available for Group Registrations?
Who are the Key Speakers at the Summit?
The summit features expert speakers from leading organizations, including:
Anthony Garcia, Head of Quality Control, Kiromic BioPharma
Alison Caldwell, Group Leader - Analytical Development, Resolution Therapeutics
José Peña, Principal Scientist, Arsenal Bio
Shawna Organ, Senior Scientist - Assay Development, BlueRock Therapeutics
Jie Wei, Director of Bioanalytical Sciences, Tr1x Bio
Kathy Simon, Vice President - Global Quality, Cellectis